Home > > > > Report Detail

Global Flu Vaccine Market Growth 2020-2025

Publisher Name :
Date: 06-Oct-2020
No. of pages: 138

According to this study, over the next five years the Flu Vaccine market will register a 5.0%% CAGR in terms of revenue, the global market size will reach $ 5603.1 million by 2025, from $ 4609.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Flu Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Flu Vaccine market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Flu Vaccine, covering the supply chain analysis, impact assessment to the Flu Vaccine market size growth rate in several scenarios, and the measures to be undertaken by Flu Vaccine companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Trivalent Influenza Vaccine

- Quadrivalent Influenza Vaccine

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- For Children (6 months to 3 years)

- For Adults and Children over 3 years

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Sanofi Pasteur

- CSL

- Mylan

- Hulan Bio

- GSK

- AstraZeneca

- CCBIO

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Flu Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Flu Vaccine market by identifying its various subsegments.

- Focuses on the key global Flu Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Flu Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Flu Vaccine submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Flu Vaccine Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Flu Vaccine Consumption 2015-2025
2.1.2 Flu Vaccine Consumption CAGR by Region
2.2 Flu Vaccine Segment by Type
2.2.1 Trivalent Influenza Vaccine
2.2.2 Quadrivalent Influenza Vaccine
2.3 Flu Vaccine Consumption by Type
2.3.1 Global Flu Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global Flu Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Flu Vaccine Sale Price by Type (2015-2020)
2.4 Flu Vaccine Segment by Application
2.4.1 For Children (6 months to 3 years)
2.4.2 For Adults and Children over 3 years
2.5 Flu Vaccine Consumption by Application
2.5.1 Global Flu Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global Flu Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global Flu Vaccine Sale Price by Type (2015-2020)

3 Global Flu Vaccine by Company
3.1 Global Flu Vaccine Sales Market Share by Company
3.1.1 Global Flu Vaccine Sales by Company (2018-2020)
3.1.2 Global Flu Vaccine Sales Market Share by Company (2018-2020)
3.2 Global Flu Vaccine Revenue Market Share by Company
3.2.1 Global Flu Vaccine Revenue by Company (2018-2020)
3.2.2 Global Flu Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global Flu Vaccine Sale Price by Company
3.4 Global Flu Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Flu Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Flu Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Flu Vaccine by Regions
4.1 Flu Vaccine by Regions
4.2 Americas Flu Vaccine Consumption Growth
4.3 APAC Flu Vaccine Consumption Growth
4.4 Europe Flu Vaccine Consumption Growth
4.5 Middle East & Africa Flu Vaccine Consumption Growth

5 Americas
5.1 Americas Flu Vaccine Consumption by Countries
5.1.1 Americas Flu Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas Flu Vaccine Value by Countries (2015-2020)
5.2 Americas Flu Vaccine Consumption by Type
5.3 Americas Flu Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Flu Vaccine Consumption by Regions
6.1.1 APAC Flu Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC Flu Vaccine Value by Regions (2015-2020)
6.2 APAC Flu Vaccine Consumption by Type
6.3 APAC Flu Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Flu Vaccine by Countries
7.1.1 Europe Flu Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe Flu Vaccine Value by Countries (2015-2020)
7.2 Europe Flu Vaccine Consumption by Type
7.3 Europe Flu Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Flu Vaccine by Countries
8.1.1 Middle East & Africa Flu Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Flu Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa Flu Vaccine Consumption by Type
8.3 Middle East & Africa Flu Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Flu Vaccine Distributors
10.3 Flu Vaccine Customer

11 Global Flu Vaccine Market Forecast
11.1 Global Flu Vaccine Consumption Forecast (2021-2025)
11.2 Global Flu Vaccine Forecast by Regions
11.2.1 Global Flu Vaccine Forecast by Regions (2021-2025)
11.2.2 Global Flu Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Flu Vaccine Forecast by Type
11.8 Global Flu Vaccine Forecast by Application

12 Key Players Analysis
12.1 Sanofi Pasteur
12.1.1 Company Information
12.1.2 Flu Vaccine Product Offered
12.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Sanofi Pasteur Latest Developments
12.2 CSL
12.2.1 Company Information
12.2.2 Flu Vaccine Product Offered
12.2.3 CSL Flu Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CSL Latest Developments
12.3 Mylan
12.3.1 Company Information
12.3.2 Flu Vaccine Product Offered
12.3.3 Mylan Flu Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Mylan Latest Developments
12.4 Hulan Bio
12.4.1 Company Information
12.4.2 Flu Vaccine Product Offered
12.4.3 Hulan Bio Flu Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Hulan Bio Latest Developments
12.5 GSK
12.5.1 Company Information
12.5.2 Flu Vaccine Product Offered
12.5.3 GSK Flu Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 GSK Latest Developments
12.6 AstraZeneca
12.6.1 Company Information
12.6.2 Flu Vaccine Product Offered
12.6.3 AstraZeneca Flu Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 AstraZeneca Latest Developments
12.7 CCBIO
12.7.1 Company Information
12.7.2 Flu Vaccine Product Offered
12.7.3 CCBIO Flu Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 CCBIO Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Flu Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Trivalent Influenza Vaccine
Table 5. Major Players of Quadrivalent Influenza Vaccine
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Flu Vaccine Consumption Market Share by Type (2015-2020)
Table 8. Global Flu Vaccine Revenue by Type (2015-2020) ($ million)
Table 9. Global Flu Vaccine Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Flu Vaccine Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Flu Vaccine Consumption Market Share by Application (2015-2020)
Table 13. Global Flu Vaccine Value by Application (2015-2020)
Table 14. Global Flu Vaccine Value Market Share by Application (2015-2020)
Table 15. Global Flu Vaccine Sale Price by Application (2015-2020)
Table 16. Global Flu Vaccine Sales by Company (2017-2019) (M Doses)
Table 17. Global Flu Vaccine Sales Market Share by Company (2017-2019)
Table 18. Global Flu Vaccine Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Flu Vaccine Revenue Market Share by Company (2017-2019)
Table 20. Global Flu Vaccine Sale Price by Company (2017-2019)
Table 21. Global Flu Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Flu Vaccine Products Offered
Table 23. Flu Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Flu Vaccine Consumption by Regions 2015-2020 (M Doses)
Table 25. Global Flu Vaccine Consumption Market Share by Regions 2015-2020
Table 26. Global Flu Vaccine Value by Regions 2015-2020 ($ Millions)
Table 27. Global Flu Vaccine Value Market Share by Regions 2015-2020
Table 28. Americas Flu Vaccine Consumption by Countries (2015-2020) (M Doses)
Table 29. Americas Flu Vaccine Consumption Market Share by Countries (2015-2020)
Table 30. Americas Flu Vaccine Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Flu Vaccine Value Market Share by Countries (2015-2020)
Table 32. Americas Flu Vaccine Consumption by Type (2015-2020) (M Doses)
Table 33. Americas Flu Vaccine Consumption Market Share by Type (2015-2020)
Table 34. Americas Flu Vaccine Consumption by Application (2015-2020) (M Doses)
Table 35. Americas Flu Vaccine Consumption Market Share by Application (2015-2020)
Table 36. APAC Flu Vaccine Consumption by Countries (2015-2020) (M Doses)
Table 37. APAC Flu Vaccine Consumption Market Share by Countries (2015-2020)
Table 38. APAC Flu Vaccine Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Flu Vaccine Value Market Share by Regions (2015-2020)
Table 40. APAC Flu Vaccine Consumption by Type (2015-2020) (M Doses)
Table 41. APAC Flu Vaccine Consumption Market Share by Type (2015-2020)
Table 42. APAC Flu Vaccine Consumption by Application (2015-2020) (M Doses)
Table 43. APAC Flu Vaccine Consumption Market Share by Application (2015-2020)
Table 44. Europe Flu Vaccine Consumption by Countries (2015-2020) (M Doses)
Table 45. Europe Flu Vaccine Consumption Market Share by Countries (2015-2020)
Table 46. Europe Flu Vaccine Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Flu Vaccine Value Market Share by Countries (2015-2020)
Table 48. Europe Flu Vaccine Consumption by Type (2015-2020) (M Doses)
Table 49. Europe Flu Vaccine Consumption Market Share by Type (2015-2020)
Table 50. Europe Flu Vaccine Consumption by Application (2015-2020) (M Doses)
Table 51. Europe Flu Vaccine Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Flu Vaccine Consumption by Countries (2015-2020) (M Doses)
Table 53. Middle East & Africa Flu Vaccine Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Flu Vaccine Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Flu Vaccine Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Flu Vaccine Consumption by Type (2015-2020) (M Doses)
Table 57. Middle East & Africa Flu Vaccine Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Flu Vaccine Consumption by Application (2015-2020) (M Doses)
Table 59. Middle East & Africa Flu Vaccine Consumption Market Share by Application (2015-2020)
Table 60. Flu Vaccine Distributors List
Table 61. Flu Vaccine Customer List
Table 62. Global Flu Vaccine Consumption Forecast by Countries (2021-2025) (M Doses)
Table 63. Global Flu Vaccine Consumption Market Forecast by Regions
Table 64. Global Flu Vaccine Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Flu Vaccine Value Market Share Forecast by Regions
Table 66. Global Flu Vaccine Consumption Forecast by Type (2021-2025) (M Doses)
Table 67. Global Flu Vaccine Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Flu Vaccine Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Flu Vaccine Value Market Share Forecast by Type (2021-2025)
Table 70. Global Flu Vaccine Consumption Forecast by Application (2021-2025) (M Doses)
Table 71. Global Flu Vaccine Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Flu Vaccine Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Flu Vaccine Value Market Share Forecast by Application (2021-2025)
Table 74. Sanofi Pasteur Product Offered
Table 75. Sanofi Pasteur Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 76. Sanofi Pasteur Main Business
Table 77. Sanofi Pasteur Latest Developments
Table 78. Sanofi Pasteur Basic Information, Company Total Revenue (in $ million), Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. CSL Product Offered
Table 80. CSL Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 81. CSL Main Business
Table 82. CSL Latest Developments
Table 83. CSL Basic Information, Company Total Revenue (in $ million), Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Mylan Product Offered
Table 85. Mylan Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 86. Mylan Main Business
Table 87. Mylan Latest Developments
Table 88. Mylan Basic Information, Company Total Revenue (in $ million), Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Hulan Bio Product Offered
Table 90. Hulan Bio Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 91. Hulan Bio Main Business
Table 92. Hulan Bio Latest Developments
Table 93. Hulan Bio Basic Information, Company Total Revenue (in $ million), Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. GSK Product Offered
Table 95. GSK Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 96. GSK Main Business
Table 97. GSK Latest Developments
Table 98. GSK Basic Information, Company Total Revenue (in $ million), Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. AstraZeneca Product Offered
Table 100. AstraZeneca Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)
Table 101. AstraZeneca Main Business
Table 102. AstraZeneca Latest Developments
Table 103. AstraZeneca Basic Information, Company Total Revenue (in $ million), Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. CCBIO Product Offered
Table 105. CCBIO Basic Information, Company Total Revenue (in $ million), Flu Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. CCBIO Main Business
Table 107. CCBIO Latest Developments
Table 108. CCBIO Flu Vaccine Sales (M Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2020E)

List of Figures

Figure 1. Picture of Flu Vaccine
Figure 2. Flu Vaccine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Flu Vaccine Consumption Growth Rate 2015-2025 (M Doses)
Figure 5. Global Flu Vaccine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Trivalent Influenza Vaccine
Figure 7. Product Picture of Quadrivalent Influenza Vaccine
Figure 8. Global Flu Vaccine Consumption Market Share by Type (2015-2020)
Figure 9. Global Flu Vaccine Value Market Share by Type (2015-2020)
Figure 10. Flu Vaccine Consumed in For Children (6 months to 3 years)
Figure 11. Global Flu Vaccine Market: For Children (6 months to 3 years) (2015-2020) (M Doses)
Figure 12. Global Flu Vaccine Market: For Children (6 months to 3 years) (2015-2020) ($ Millions)
Figure 13. Flu Vaccine Consumed in For Adults and Children over 3 years
Figure 14. Global Flu Vaccine Market: For Adults and Children over 3 years (2015-2020) (M Doses)
Figure 15. Global Flu Vaccine Market: For Adults and Children over 3 years (2015-2020) ($ Millions)
Figure 16. Global Flu Vaccine Consumption Market Share by Application (2015-2020)
Figure 17. Global Flu Vaccine Value Market Share by Application (2015-2020)
Figure 18. Global Flu Vaccine Sales Market Share by Company in 2017
Figure 19. Global Flu Vaccine Sales Market Share by Company in 2019
Figure 20. Global Flu Vaccine Revenue Market Share by Company in 2017
Figure 21. Global Flu Vaccine Revenue Market Share by Company in 2019
Figure 22. Global Flu Vaccine Sale Price by Company in 2019
Figure 23. Global Flu Vaccine Consumption Market Share by Regions 2015-2020
Figure 24. Global Flu Vaccine Value Market Share by Regions 2015-2020
Figure 25. Americas Flu Vaccine Consumption 2015-2020 (M Doses)
Figure 26. Americas Flu Vaccine Value 2015-2020 ($ Millions)
Figure 27. APAC Flu Vaccine Consumption 2015-2020 (M Doses)
Figure 28. APAC Flu Vaccine Value 2015-2020 ($ Millions)
Figure 29. Europe Flu Vaccine Consumption 2015-2020 (M Doses)
Figure 30. Europe Flu Vaccine Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Flu Vaccine Consumption 2015-2020 (M Doses)
Figure 32. Middle East & Africa Flu Vaccine Value 2015-2020 ($ Millions)
Figure 33. Americas Flu Vaccine Consumption Market Share by Countries in 2019
Figure 34. Americas Flu Vaccine Value Market Share by Countries in 2019
Figure 35. Americas Flu Vaccine Consumption Market Share by Type in 2019
Figure 36. Americas Flu Vaccine Consumption Market Share by Application in 2019
Figure 37. United States Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 38. United States Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 40. Canada Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 42. Mexico Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Flu Vaccine Consumption Market Share by Countries in 2019
Figure 44. APAC Flu Vaccine Value Market Share by Regions in 2019
Figure 45. APAC Flu Vaccine Consumption Market Share by Type in 2019
Figure 46. APAC Flu Vaccine Consumption Market Share by Application in 2019
Figure 47. China Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 48. China Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 50. Japan Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 52. Korea Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 54. Southeast Asia Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 55. India Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 56. India Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 58. Australia Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Flu Vaccine Consumption Market Share by Countries in 2019
Figure 60. Europe Flu Vaccine Value Market Share by Countries in 2019
Figure 61. Europe Flu Vaccine Consumption Market Share by Type in 2019
Figure 62. Europe Flu Vaccine Consumption Market Share by Application in 2019
Figure 63. Germany Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 64. Germany Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 65. France Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 66. France Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 67. UK Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 68. UK Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 70. Italy Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 72. Russia Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Flu Vaccine Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Flu Vaccine Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Flu Vaccine Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Flu Vaccine Consumption Market Share by Application in 2019
Figure 77. Egypt Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 78. Egypt Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 80. South Africa Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 82. Israel Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 84. Turkey Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Flu Vaccine Consumption Growth 2015-2020 (M Doses)
Figure 86. GCC Countries Flu Vaccine Value Growth 2015-2020 ($ Millions)
Figure 87. Global Flu Vaccine Consumption Growth Rate Forecast (2021-2025) (M Doses)
Figure 88. Global Flu Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 90. Americas Flu Vaccine Value 2021-2025 ($ Millions)
Figure 91. APAC Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 92. APAC Flu Vaccine Value 2021-2025 ($ Millions)
Figure 93. Europe Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 94. Europe Flu Vaccine Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 96. Middle East & Africa Flu Vaccine Value 2021-2025 ($ Millions)
Figure 97. United States Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 98. United States Flu Vaccine Value 2021-2025 ($ Millions)
Figure 99. Canada Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 100. Canada Flu Vaccine Value 2021-2025 ($ Millions)
Figure 101. Mexico Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 102. Mexico Flu Vaccine Value 2021-2025 ($ Millions)
Figure 103. Brazil Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 104. Brazil Flu Vaccine Value 2021-2025 ($ Millions)
Figure 105. China Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 106. China Flu Vaccine Value 2021-2025 ($ Millions)
Figure 107. Japan Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 108. Japan Flu Vaccine Value 2021-2025 ($ Millions)
Figure 109. Korea Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 110. Korea Flu Vaccine Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 112. Southeast Asia Flu Vaccine Value 2021-2025 ($ Millions)
Figure 113. India Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 114. India Flu Vaccine Value 2021-2025 ($ Millions)
Figure 115. Australia Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 116. Australia Flu Vaccine Value 2021-2025 ($ Millions)
Figure 117. Germany Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 118. Germany Flu Vaccine Value 2021-2025 ($ Millions)
Figure 119. France Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 120. France Flu Vaccine Value 2021-2025 ($ Millions)
Figure 121. UK Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 122. UK Flu Vaccine Value 2021-2025 ($ Millions)
Figure 123. Italy Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 124. Italy Flu Vaccine Value 2021-2025 ($ Millions)
Figure 125. Russia Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 126. Russia Flu Vaccine Value 2021-2025 ($ Millions)
Figure 127. Spain Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 128. Spain Flu Vaccine Value 2021-2025 ($ Millions)
Figure 129. Egypt Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 130. Egypt Flu Vaccine Value 2021-2025 ($ Millions)
Figure 131. South Africa Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 132. South Africa Flu Vaccine Value 2021-2025 ($ Millions)
Figure 133. Israel Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 134. Israel Flu Vaccine Value 2021-2025 ($ Millions)
Figure 135. Turkey Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 136. Turkey Flu Vaccine Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Flu Vaccine Consumption 2021-2025 (M Doses)
Figure 138. GCC Countries Flu Vaccine Value 2021-2025 ($ Millions)
Figure 139. Sanofi Pasteur Flu Vaccine Market Share (2018-2020)
Figure 140. CSL Flu Vaccine Market Share (2018-2020)
Figure 141. Mylan Flu Vaccine Market Share (2018-2020)
Figure 142. Hulan Bio Flu Vaccine Market Share (2018-2020)
Figure 143. GSK Flu Vaccine Market Share (2018-2020)
Figure 144. AstraZeneca Flu Vaccine Market Share (2018-2020)
Figure 145. CCBIO Flu Vaccine Market Share (2018-2020)
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs